HK1212605A1 - 具有所需生物利用度的藥物組合物 - Google Patents

具有所需生物利用度的藥物組合物

Info

Publication number: HK1212605A1
Authority: HK; Hong Kong
Prior art keywords: pharmaceutical compositions; desirable bioavailability; bioavailability; desirable; pharmaceutical
Prior art date: 2008-03-17

Application number

HK16100544.3A

Other languages

English (en)

Inventor

Bhagwati P Kabra

Nuria Carreras

Mnica Cuchi

Francisco Javier Galn

Mridvika

Elena Gonzlez Puig

Nuria Jimnez

Carmen Martnez

Original Assignee

Alcon Res Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-03-17

Filing date

2016-01-19

Publication date

2016-06-17

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41037889&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1212605(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2016-01-19 Application filed by Alcon Res Ltd filed Critical Alcon Res Ltd

2016-06-17 Publication of HK1212605A1 publication Critical patent/HK1212605A1/zh

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Ophthalmology & Optometry (AREA)
Emergency Medicine (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Oil, Petroleum & Natural Gas (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

HK16100544.3A 2008-03-17 2016-01-19 具有所需生物利用度的藥物組合物 HK1212605A1 (zh)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US3711708P	2008-03-17	2008-03-17
US11192008P	2008-11-06	2008-11-06

Publications (1)

Publication Number	Publication Date
HK1212605A1 true HK1212605A1 (zh)	2016-06-17

Family

ID=41037889

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
HK16100544.3A HK1212605A1 (zh)	2008-03-17	2016-01-19	具有所需生物利用度的藥物組合物
HK16108483.9A HK1220378A1 (zh)	2008-03-17	2016-07-18	具有所需生物利用度的藥物組合物

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
HK16108483.9A HK1220378A1 (zh)	2008-03-17	2016-07-18	具有所需生物利用度的藥物組合物

Country Status (24)

Country	Link
US (5)	US20090234004A1 (zh)
EP (4)	EP3042646B1 (zh)
JP (2)	JP5654444B2 (zh)
KR (1)	KR101586357B1 (zh)
CN (2)	CN105012964A (zh)
AR (1)	AR070888A1 (zh)
AU (1)	AU2009225824B2 (zh)
BR (1)	BRPI0908717B1 (zh)
CA (1)	CA2716994C (zh)
CL (1)	CL2009000624A1 (zh)
DE (2)	DE202009019114U1 (zh)
DK (3)	DK2265251T3 (zh)
ES (3)	ES2637028T3 (zh)
HK (2)	HK1212605A1 (zh)
HU (1)	HUE025619T2 (zh)
MX (1)	MX2010009570A (zh)
PL (1)	PL2265251T3 (zh)
PT (1)	PT2265251E (zh)
RU (1)	RU2503453C2 (zh)
SI (1)	SI2265251T1 (zh)
TW (1)	TWI544927B (zh)
UY (1)	UY31716A1 (zh)
WO (1)	WO2009117316A2 (zh)
ZA (1)	ZA201006227B (zh)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI544927B (zh)	2008-03-17	2016-08-11	愛爾康研究有限公司	具有低濃度的表面活性劑以促進治療劑之生物可利用性的藥學組成物
ES2443548T5 (es)	2008-03-17	2020-01-23	Alcon Res Ltd	Composiciones farmacéuticas acuosas que contienen complejos de borato-poliol
TWI489997B (zh)	2009-06-19	2015-07-01	Alcon Res Ltd	含有硼酸－多元醇錯合物之水性藥學組成物
WO2012012476A1 (en) *	2010-07-21	2012-01-26	Alcon Research, Ltd.	Pharmaceutical composition with enhanced solubility characteristics
EP2452669A1 (en)	2010-10-29	2012-05-16	Omnivision GmbH	Ophthalmic composition
FI2887923T3 (fi) *	2012-08-24	2023-06-30	Sun Pharmaceutical Ind Ltd	Polyoksylilipidin tai polyoksylirasvahapon oftalminen formulaatio ja silmätilojen hoito
UA118576C2 (uk) *	2014-01-24	2019-02-11	Сентис Фарма Прайвет Лімітед	Фармацевтична композиція, яка містить бринзоламід
EP2937076B1 (en) *	2014-04-25	2019-09-11	Alfred E. Tiefenbacher (GmbH & Co. KG)	Eye drops containing prostaglandin and tyloxapol
MX2016015211A (es) *	2014-05-23	2017-06-20	Ocular Tech Sarl	Formulaciones topicas y usos de las mismas.
EA034839B1 (ru) *	2014-10-20	2020-03-26	Сентисс Фарма Прайвет Лимитед	Офтальмологический раствор
US11458041B2 (en)	2015-10-08	2022-10-04	Ocular Therapeutix, Inc.	Punctal plug and bioadhesives
DK3373976T3 (da)	2015-11-10	2024-04-02	Sun Pharmaceutical Ind Ltd	Topiske formuleringer og anvendelser deraf
EP3373924A4 (en) *	2015-11-12	2019-06-19	Sun Pharma Global FZE	TOPICAL FORMULATIONS AND USES THEREOF
MX2018010395A (es)	2016-02-29	2018-11-29	Sun Pharma Global Fze	Formulaciones topicas que contienen cliclosporina y usos de las mismas.
WO2021158968A1 (en)	2020-02-06	2021-08-12	Ocular Therapeutix, Inc.	Compositions and methods for treating ocular diseases
TWI819317B (zh) *	2021-06-07	2023-10-21	溫士頓醫藥股份有限公司	含前列腺素衍生物的眼用奈米乳劑組合物

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3711708A (en)	1971-02-25	1973-01-16	Optical Coating Laboratory Inc	Rapid scan identifier for use in infrared absorption spectroscopy
US4027020A (en)	1974-10-29	1977-05-31	Millmaster Onyx Corporation	Randomly terminated capped polymers
US3931319A (en) *	1974-10-29	1976-01-06	Millmaster Onyx Corporation	Capped polymers
GB2084870B (en) *	1980-10-10	1985-05-09	Muhlemann R Hans	Oral compositions containing pyrimidine amine compounds and zinc salts
US4525346A (en) *	1981-09-28	1985-06-25	Alcon Laboratories, Inc.	Aqueous antimicrobial ophthalmic solutions
US4407791A (en)	1981-09-28	1983-10-04	Alcon Laboratories, Inc.	Ophthalmic solutions
US4836986A (en)	1984-09-28	1989-06-06	Bausch & Lomb Incorporated	Disinfecting and preserving systems and methods of use
US5037647A (en)	1988-09-15	1991-08-06	Alcon Laboratories, Inc.	Aqueous antimicrobial opthalmic solutions comprised of quaternary ammonium compound, citric acid, citrate and sodium chloride
US5145643A (en)	1990-01-05	1992-09-08	Allergan, Inc.	Nonoxidative ophthalmic compositions and methods for preserving and using same
US5221664A (en)	1990-04-23	1993-06-22	Magainin Pharmaaceuticals Inc.	Composition and treatment with biologically active peptides and toxic cations
UA26334A (uk) *	1990-12-27	1999-08-30	Еллергаh Іhк.	Спосіб дезиhфекції коhтактhих ліhз та композиція для дезиhфекції коhтактhих ліhз
US5932572A (en) *	1992-02-21	1999-08-03	Alcon Laboratories, Inc.	Topical anti-glaucoma compositions
US5505953A (en)	1992-05-06	1996-04-09	Alcon Laboratories, Inc.	Use of borate-polyol complexes in ophthalmic compositions
US5300287A (en) *	1992-11-04	1994-04-05	Alcon Laboratories, Inc.	Polymeric antimicrobials and their use in pharmaceutical compositions
US5320843A (en)	1992-12-10	1994-06-14	Polymer Technology Corporation	Method for improving antibacterial properties of ophthalmic solutions
AU3070395A (en)	1994-07-22	1996-02-22	Alcon Laboratories, Inc.	Use of low molecular weight amino acids in ophthalmic compositions
US5603929A (en)	1994-11-16	1997-02-18	Alcon Laboratories, Inc.	Preserved ophthalmic drug compositions containing polymeric quaternary ammonium compounds
US6011062A (en)	1994-12-22	2000-01-04	Alcon Laboratories, Inc.	Storage-stable prostaglandin compositions
US5631287A (en) *	1994-12-22	1997-05-20	Alcon Laboratories, Inc.	Storage-stable prostaglandin compositions
BR9607808A (pt)	1995-03-20	1998-07-07	Unilever Nv	Composição para limpeza da pele e processo para realçar o efeito antimicrobiano das formulações para limpeza da pele
HU225329B1 (en) *	1996-09-12	2006-09-28	Richter Gedeon Vegyeszet	Use of zinc or cobalt hyaluronate associate for the manufacture of pharmaceutical compositions of antimicrobial activity
JP2001504100A (ja) *	1996-11-01	2001-03-27	アルコン・ラボラトリーズ・インコーポレーテッド	緑内障を治療するための炭酸脱水素酵素阻害剤とプロスタグランジンとの組合せの使用
GB9624928D0 (en)	1996-11-29	1997-01-15	Lintrend Developments Ni Ltd	Fibrous products and their production
US6071904A (en)	1996-12-11	2000-06-06	Alcon Laboratories, Inc.	Process for manufacturing ophthalmic suspensions
ES2178786T3 (es) *	1996-12-13	2003-01-01	Alcon Lab Inc	Uso de aminoalcoholes de bajo peso molecular en composiciones oftalmicos.
AR002194A1 (es) *	1997-03-17	1998-01-07	Sanchez Reynaldo Alemany	Instrumento computarizado para el analisis del movimiento.
EP0998277A1 (en)	1997-05-30	2000-05-10	Merck & Co., Inc. (a New Jersey corp.)	Ophthalmic compositions for treating ocular hypertension
US6235781B1 (en) *	1998-07-14	2001-05-22	Alcon Laboratories, Inc.	Prostaglandin product
DE69922916T2 (de) *	1998-07-14	2005-06-09	Alcon Manufacturing Ltd., Fort Worth	Polypropylenbasierte behälter für prostaglandin-enthaltende produkte
US6034043A (en)	1999-04-20	2000-03-07	Lever Brothers Company, Division Of Conopco, Inc.	Mild antimicrobial liquid cleansing formulations comprising polyvalent cation or cations for improving an antimicrobial effectiveness
US6482799B1 (en) *	1999-05-25	2002-11-19	The Regents Of The University Of California	Self-preserving multipurpose ophthalmic solutions incorporating a polypeptide antimicrobial
US20020009507A1 (en)	2000-01-19	2002-01-24	Alcon Universal Ltd.	Use of polyethoxylated castor oil for the treatment of dry eye
DK1321144T3 (da)	2000-09-13	2011-03-07	Santen Pharmaceutical Co Ltd	Øjendråber
WO2002043482A2 (en)	2000-11-29	2002-06-06	Novartis Ag	Aqueous disinfecting systems
JP2002332225A (ja) *	2001-05-09	2002-11-22	Lion Corp	眼科用組成物
DE10222388A1 (de) *	2001-05-22	2003-02-13	Denso Corp	Kompressor mit veränderbarer Verdrängung
US6743439B1 (en) *	2001-06-27	2004-06-01	Alcon, Inc.	Ophthalmic compositions containing copolymers of sulfonated styrene and maleic anhydride
JP4863589B2 (ja)	2001-09-28	2012-01-25	ロート製薬株式会社	水性組成物
CA2707067C (en) *	2002-09-09	2013-07-16	Santen Pharmaceutical Co., Ltd.	Clear ophthalmic solution comprising latanoprost as active ingredient
US7074827B2 (en)	2002-10-24	2006-07-11	Sucampo Ag (Usa) Inc.	Method for treating ocular hypertension and glaucoma
ATE450264T1 (de)	2003-07-31	2009-12-15	Santen Pharmaceutical Co Ltd	Prostaglandin enthaltendes produkt
JP4453815B2 (ja) *	2003-12-08	2010-04-21	ライオン株式会社	ドライアイ治療剤
JP2005247801A (ja) *	2004-03-08	2005-09-15	Zeria Pharmaceut Co Ltd	安定な点眼剤
CA2563365A1 (en)	2004-04-23	2005-11-03	Mystic Pharmaceuticals, Inc.	Multiple unit dose drug delivery system
GB0501192D0 (en)	2005-01-20	2005-03-02	Resolution Chemicals Ltd	Stable prostaglandin-containing compositions
US7851504B2 (en)	2005-03-16	2010-12-14	Allergan, Inc.	Enhanced bimatoprost ophthalmic solution
PL2066300T5 (pl)	2006-09-28	2020-03-31	Novartis Ag	Samokonserwujące wodne kompozycje farmaceutyczne
US20080095863A1 (en)	2006-10-24	2008-04-24	Alcon Manufacturing Ltd.	2-pyrrolidone derivatives for preservation of ophthalmic, otic and nasal compositions
US20080093247A1 (en) *	2006-10-24	2008-04-24	Alcon Manufacturing Ltd.	Packaging materials for formulations containing 2-pyrrolidone derivatives
US20100120908A1 (en) *	2007-02-07	2010-05-13	Teika Pharmaceutical Co., Ltd	Eye drop preparation comprising latanoprost
TWI544927B (zh) *	2008-03-17	2016-08-11	愛爾康研究有限公司	具有低濃度的表面活性劑以促進治療劑之生物可利用性的藥學組成物
EP2127638A1 (en)	2008-05-30	2009-12-02	Santen Pharmaceutical Co., Ltd	Method and composition for treating ocular hypertension and glaucoma
EP3975794B1 (en)	2019-05-31	2024-10-09	Karsten Manufacturing Corporation	Golf bag convertible strap assembly

2009
- 2009-03-12 TW TW098108014A patent/TWI544927B/zh active
- 2009-03-13 EP EP15202422.0A patent/EP3042646B1/en not_active Revoked
- 2009-03-13 ES ES15202422.0T patent/ES2637028T3/es active Active
- 2009-03-13 EP EP09722278.0A patent/EP2265251B1/en active Active
- 2009-03-13 KR KR1020107022614A patent/KR101586357B1/ko active IP Right Review Request
- 2009-03-13 BR BRPI0908717-6A patent/BRPI0908717B1/pt active IP Right Grant
- 2009-03-13 DK DK09722278.0T patent/DK2265251T3/en active
- 2009-03-13 US US12/403,543 patent/US20090234004A1/en not_active Abandoned
- 2009-03-13 DE DE202009019114.1U patent/DE202009019114U1/de not_active Expired - Lifetime
- 2009-03-13 AU AU2009225824A patent/AU2009225824B2/en active Active
- 2009-03-13 CN CN201510501617.6A patent/CN105012964A/zh active Pending
- 2009-03-13 DK DK12193597.7T patent/DK2599475T3/en active
- 2009-03-13 DE DE202009019087.0U patent/DE202009019087U1/de not_active Expired - Lifetime
- 2009-03-13 RU RU2010142307/15A patent/RU2503453C2/ru active
- 2009-03-13 MX MX2010009570A patent/MX2010009570A/es active IP Right Grant
- 2009-03-13 PL PL09722278T patent/PL2265251T3/pl unknown
- 2009-03-13 CN CN2009801092915A patent/CN101977588A/zh active Pending
- 2009-03-13 CA CA2716994A patent/CA2716994C/en not_active Expired - Fee Related
- 2009-03-13 JP JP2011500876A patent/JP5654444B2/ja active Active
- 2009-03-13 EP EP13184332.8A patent/EP2705836A1/en not_active Withdrawn
- 2009-03-13 SI SI200931225T patent/SI2265251T1/sl unknown
- 2009-03-13 DK DK15202422.0T patent/DK3042646T3/en active
- 2009-03-13 AR ARP090100905A patent/AR070888A1/es not_active Application Discontinuation
- 2009-03-13 US US12/403,529 patent/US8178582B2/en active Active
- 2009-03-13 ES ES09722278.0T patent/ES2542728T3/es active Active
- 2009-03-13 PT PT97222780T patent/PT2265251E/pt unknown
- 2009-03-13 EP EP12193597.7A patent/EP2599475B1/en active Active
- 2009-03-13 WO PCT/US2009/037077 patent/WO2009117316A2/en active Search and Examination
- 2009-03-13 ES ES12193597.7T patent/ES2635197T3/es active Active
- 2009-03-13 HU HUE09722278A patent/HUE025619T2/en unknown
- 2009-03-16 UY UY031716A patent/UY31716A1/es not_active Application Discontinuation
- 2009-03-16 CL CL2009000624A patent/CL2009000624A1/es unknown
2010
- 2010-08-31 ZA ZA2010/06227A patent/ZA201006227B/en unknown
2011
- 2011-10-04 US US13/252,255 patent/US8722735B2/en active Active
2012
- 2012-04-09 US US13/442,475 patent/US8754123B2/en active Active
2013
- 2013-10-23 JP JP2013219982A patent/JP2014012744A/ja not_active Withdrawn
2014
- 2014-05-01 US US14/267,668 patent/US9144561B2/en active Active
2016
- 2016-01-19 HK HK16100544.3A patent/HK1212605A1/zh unknown
- 2016-07-18 HK HK16108483.9A patent/HK1220378A1/zh not_active IP Right Cessation

Also Published As

Publication number	Publication date
CA2716994C (en)	2013-05-28
MX2010009570A (es)	2010-09-28
DK2599475T3 (en)	2017-08-21
US20090234004A1 (en)	2009-09-17
EP2599475A3 (en)	2013-08-21
AU2009225824B2 (en)	2014-04-10
EP2265251B1 (en)	2015-05-27
DE202009019087U1 (de)	2016-05-20
PT2265251E (pt)	2015-09-01
ES2542728T3 (es)	2015-08-10
EP2599475B1 (en)	2017-04-26
BRPI0908717B1 (pt)	2021-12-21
WO2009117316A3 (en)	2010-09-10
CN105012964A (zh)	2015-11-04
UY31716A1 (es)	2009-08-31
CN101977588A (zh)	2011-02-16
US8754123B2 (en)	2014-06-17
DK3042646T3 (en)	2017-08-28
US20140243409A1 (en)	2014-08-28
HUE025619T2 (en)	2016-04-28
KR20110005801A (ko)	2011-01-19
WO2009117316A2 (en)	2009-09-24
EP3042646A1 (en)	2016-07-13
CL2009000624A1 (es)	2010-01-04
SI2265251T1 (sl)	2015-08-31
JP2014012744A (ja)	2014-01-23
EP2705836A1 (en)	2014-03-12
RU2010142307A (ru)	2012-04-27
DK2265251T3 (en)	2015-06-29
JP2011514384A (ja)	2011-05-06
EP3042646B1 (en)	2017-05-10
EP2265251A2 (en)	2010-12-29
TW200940068A (en)	2009-10-01
AR070888A1 (es)	2010-05-12
US20120029073A1 (en)	2012-02-02
AU2009225824A1 (en)	2009-09-24
CA2716994A1 (en)	2009-09-24
BRPI0908717A2 (pt)	2020-12-01
ZA201006227B (en)	2012-02-29
EP2599475A2 (en)	2013-06-05
JP5654444B2 (ja)	2015-01-14
ES2635197T3 (es)	2017-10-02
ES2637028T3 (es)	2017-10-10
US20120245227A1 (en)	2012-09-27
PL2265251T3 (pl)	2015-10-30
TWI544927B (zh)	2016-08-11
HK1220378A1 (zh)	2017-05-05
RU2503453C2 (ru)	2014-01-10
US8178582B2 (en)	2012-05-15
US8722735B2 (en)	2014-05-13
KR101586357B1 (ko)	2016-01-18
US9144561B2 (en)	2015-09-29
DE202009019114U1 (de)	2016-08-01
US20090234013A1 (en)	2009-09-17

Publication	Publication Date	Title
HK1220378A1 (zh)	2017-05-05	具有所需生物利用度的藥物組合物
IL247741A0 (en)	2016-11-30	pharmaceutical preparations
EP2240022A4 (en)	2012-04-25	PHARMACEUTICAL COMPOSITIONS
GB0814695D0 (en)	2008-09-17	Pharmaceutical compositions
EP2373681A4 (en)	2013-11-06	PHARMACEUTICAL COMPOSITIONS
EP2227085A4 (en)	2013-10-09	INGREDIBLE COMPOSITIONS WITH INCREASED BIOLOGICAL AVAILABILITY
PT2323623T (pt)	2016-11-04	Composições farmacêuticas
EP2451274A4 (en)	2014-04-02	PHARMACEUTICAL COMPOSITIONS
EP2222313A4 (en)	2011-02-16	PHARMACEUTICAL COMPOSITIONS
SG2014012405A (en)	2014-05-29	Pharmaceutical compositions
EP2146695A4 (en)	2010-05-19	PHARMACEUTICAL COMPOSITIONS
GB0709811D0 (en)	2007-07-04	Pharmaceutical compositions
GB0707127D0 (en)	2007-05-23	Pharmaceutical compositions
IL206487A0 (en)	2010-12-30	Pharmaceutical compositions
EP2488175A4 (en)	2013-08-07	PHARMACEUTICAL COMPOSITIONS
GB0712454D0 (en)	2007-08-08	Pharmaceutical compositions
GB0800659D0 (en)	2008-02-20	Pharmaceutical Compositions
GB2454923B (en)	2011-04-20	Pharmaceutical compositions
IL201394A0 (en)	2010-05-31	Niacin - based pharmaceutical compositions
GB0806156D0 (en)	2008-05-14	Pharmaceutical compositions
GB0806283D0 (en)	2008-05-14	Pharmaceutical compositions
GB0802024D0 (en)	2008-03-12	Pharmaceutical compositions
EP2308842A4 (en)	2012-03-14	PHARMACEUTICAL COMPOSITIONS
GB0804485D0 (en)	2008-04-16	Novel pharmaceutical compositions
GB0805807D0 (en)	2008-04-30	Novel pharmaceutical compositions